These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15563260)

  • 1. Comparative genomic hybridization analysis for esophageal squamous cell carcinoma.
    Oka M
    Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):275-6. PubMed ID: 15563260
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of nodal metastasis by comparative genomic hybridization in biopsy specimens from patients with superficial esophageal squamous cell carcinoma.
    Ueno T; Tangoku A; Yoshino S; Abe T; Hayashi H; Toshimitsu H; Hashimoto K; Satoh T; Oga A; Furuya T; Oka M; Sasaki K
    Clin Cancer Res; 2003 Nov; 9(14):5137-41. PubMed ID: 14613991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
    Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR
    Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and clinical evaluation of axillary lymph node metastasis in esophageal cancer.
    Komatsu S; Ueda Y; Ichikawa D; Fujiwara H; Okamoto K; Kikuchi S; Shiozaki A; Imura K; Ohsawa R; Ochiai T; Tsubokura T; Yamagishi H
    Jpn J Clin Oncol; 2007 Apr; 37(4):314-8. PubMed ID: 17553821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 6. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
    Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
    Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAC clones related to prognosis in patients with esophageal squamous carcinoma: an array comparative genomic hybridization study.
    Hirasaki S; Noguchi T; Mimori K; Onuki J; Morita K; Inoue H; Sugihara K; Mori M; Hirano T
    Oncologist; 2007 Apr; 12(4):406-17. PubMed ID: 17470683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Esophageal carcinoma in an advanced stage. The value of surgery plus radiochemotherapy].
    Theisen J; Siewert JR
    MMW Fortschr Med; 2002 Jul; 144(27-28):36-8. PubMed ID: 12198876
    [No Abstract]   [Full Text] [Related]  

  • 11. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
    Wang Z; Liu XY; Liu FY
    Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA copy number abnormality of oral squamous cell carcinoma detected with cDNA array-based comparative genomic hybridization.
    Zhou X; Jordan RC; Mok S; Birrer MJ; Wong DT
    Cancer Genet Cytogenet; 2004 May; 151(1):90-2. PubMed ID: 15120918
    [No Abstract]   [Full Text] [Related]  

  • 14. [Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy].
    Chen EC; Liu MZ; Hu YH; Li QQ; Liu H; Cai L; Liu H; Lin HX; Huang Y; Wang HY; Cui NJ
    Ai Zheng; 2005 Jun; 24(6):731-4. PubMed ID: 15946490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
    Bruzzi JF; Swisher SG; Truong MT; Munden RF; Hofstetter WL; Macapinlac HA; Correa AM; Mawlawi O; Ajani JA; Komaki RR; Fukami N; Erasmus JJ
    Cancer; 2007 Jan; 109(1):125-34. PubMed ID: 17146785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways.
    Noutomi Y; Oga A; Uchida K; Okafuji M; Ita M; Kawauchi S; Furuya T; Ueyama Y; Sasaki K
    J Pathol; 2006 Sep; 210(1):67-74. PubMed ID: 16767698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.